Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: An NRG Oncology/Gynecologic Oncology Group study

Journal article

Peer reviewed

K.S. Tewari, M. Sill, B.J. Monk, R.T. Penson, H. Lankes, M.M. Leitao, L.M. Ramondetta, L. Van Le, D.L. Richardson, L.M. Landrum, …

Gynecologic oncology, Vol.137, pp.12-12

04/01/2015

Metrics

1 Record Views

Title: Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: An NRG Oncology/Gynecologic Oncology Group study
Creators: K.S. Tewari - University of California, Irvine Medical Center
M. Sill - Gynecologic Oncology Group
B.J. Monk - University of Arizona
R.T. Penson - Massachusetts General Hospital
H. Lankes - Gynecologic Oncology Group
M.M. Leitao - Memorial Sloan Kettering Cancer Center
L.M. Ramondetta - The University of Texas MD Anderson Cancer Center
L. Van Le - University of North Carolina at Chapel Hill
D.L. Richardson - The University of Texas Southwestern Medical Center
L.M. Landrum - Oklahoma City University
P.A. DiSilvestro - Women & Infants Hospital of Rhode Island
K. Behbakht - University of Colorado Denver
F.R. Ueland - University of Kentucky
H. Michael - Indiana University
M.J. Birrer - Massachusetts General Hospital
Publication Details: Gynecologic oncology, Vol.137, pp.12-12
Publisher: Elsevier Inc
Identifiers: 991005968777702656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article